TNXP
TNXP
NASDAQ · Biotechnology

Tonix Pharmaceuticals Holdin

Biotech Stocks Healthcare Stocks
$14.44
+0.35 (+2.48%)
As of May 16, 2:05 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +182.1% upside
Low Target $28.14
Average Target $40.74
High Target $50.62
Current Price $14.44
Current
$14.44
Target
$40.74
$28.14 $40.74 avg $50.62
Scenario Analysis
Bear Case
$28.14
94.9%
Low target
Base Case
$40.74
+182.1%
Avg target
Bull Case
$50.62
+250.6%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$69.97
-79.4% from high
52-Week Low
$11.60
+24.5% from low
Target vs 52W High
$40.74
-41.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
 Buy 43 56% $91.45 -52.6%